These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9815608)

  • 1. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
    Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
    Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
    Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
    Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
    Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
    J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
    Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
    Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [K-ras mutations detection in paraaortic lymph nodes and its prognostic value after the surgical treatment of pancreas cancer].
    Agaev BA; Muslimov GF; Iagublu VSh; Babaeva NR
    Khirurgiia (Mosk); 2008; (9):64-9. PubMed ID: 18833187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
    Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of K-ras mutations with liver metastases from colorectal carcinoma.
    Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
    Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.